Search results
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 1 day agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the late-stage pipeline to support...is set to...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 2 days agoEarnings rose 48% year over year on a reported basis and 54% excluding foreign exchange (Fx) impact. Including acquisition and divestiture-related costs, restructuring costs, income and losses ...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for...
Morningstar· 4 days agoImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Designated ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 3 days agoThe RS Rating is a 1-99 measure of a stock's 12-month performance. This means Moderna stock outranks...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 20 hours agoNovartis’ Lutathera Gets FDA Nod for Rare Cancer in Kids: The FDA granted approval to Novartis’...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 3 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Why Is ImmunityBio Stock Trading Higher On Tuesday? - ImmunityBio (NASDAQ:IBRX)
Benzinga· 4 days agoThe drug is combined with the BCG vaccine, mainly used against tuberculosis and as a common treatment for some forms of bladder cancer. Last year in May, the FDA issued a ...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 6 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
FDA Roundup: April 26, 2024
Bennington Banner· 16 hours agoSILVER SPRING, Md., April 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 2 days agoMerck noted that the devaluation of the Argentine peso had a 2% impact on sales. Minus that factor,...
